logologo
QuantliQuantli

Humacyte Inc

HUMA

NASDAQ

Biotechnology

$0.60

USD

+0.05 (+9.96%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $148.30M

Volume 33.0M

Price Target

$1.25$4.00

USD

The 4 analysts offering 1-year price forecasts have a max estimate of $4.00 and a min estimate of $1.25.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$2.31

-$3.0 vs prior

Implied Upside

+285.0%

-503.3% vs prior

Analyst Covering

4

-2 vs prior period

Consensus

Buy

Improved vs prior

Signal Quality

Consensus Freshness

40%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$0.3100 Gap

Median $2.00 vs avg $2.31 - a few bullish outliers are pulling the average up

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

4 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

4 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Joshua Jennings

TD Cowen

Buy

Maintained

2 months ago

Plus
Plus
Plus

Ryan Zimmerman

BTIG

Buy

Reiterated

2 months ago

Plus
Plus
Plus

Swayampakula Ramakanth

HC Wainwright & Co.

Buy

Maintained

2 months ago

Plus
Plus
Plus

Bruce D. Jackson

Benchmark

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

NKTX

Nkarta Inc

$2.33

+1.3%

CNTB

Connect Biopharma Holdings Ltd

$2.55

+0.4%

VYGR

Voyager Therapeutics Inc

$3.27

+1.6%

CNTN

Canton Strategic Holdings Inc

$2.02

+2.5%

CHRS

Coherus Oncology Inc

$1.20

+5.3%

CRBU

Caribou Biosciences Inc

$1.58

-1.9%

OKUR

Onkure Therapeutics Inc

$3.99

+2.3%

TNYA

Tenaya Therapeutics Inc

$0.7300

-0.7%